Table 2.
Adipokines | β | SE | OR (95% CI) | P Value |
---|---|---|---|---|
(A) Adipokines modeled separately | ||||
Leptina | −0.44 | 0.13 | 0.65 (0.50–0.83) | 0.001b |
Adiponectina | 0.25 | 0.09 | 1.28 (1.07–1.54) | 0.007b |
Leptin/adiponectina | −0.59 | 0.14 | 0.56 (0.43–0.73) | <0.001b |
Resistina | 0.06 | 0.08 | 1.06 (0.91–1.23) | 0.482 |
FGF21a | 0.00 | 0.08 | 1.00 (0.85–1.18) | 0.988 |
RBP‐4a | −0.30 | 0.09 | 0.74 (0.62–0.88) | 0.001b |
Osteonectina | −0.21 | 0.08 | 0.82 (0.70–0.96) | 0.012b |
(B) Adipokines modeled together | ||||
Leptin/adiponectina | −0.55 | 0.15 | 0.58 (0.43–0.77) | <0.001b |
RBP‐4a | −0.26 | 0.09 | 0.77 (0.64–0.93) | 0.005b |
Osteonectina | −0.20 | 0.09 | 0.82 (0.70–0.97) | 0.021b |
Data were natural logarithmically transformed, and all ORs were expressed in standard deviations and adjusted for age, pubertal stages, residence, diet score, physical activity, and body mass index. CI indicates confidence interval; FGF21, fibroblast growth factor 21; OR, odds ratio; RBP‐4, retinol binding protein 4.
Per sex‐specific standard deviation increment of each natural logarithmic unit of adipokine.
P<0.05.